2024
Lupus erythematosus and dermatomyositis
Ramachandran S, Little A, Gehlhausen J. Lupus erythematosus and dermatomyositis. Clinics In Dermatology 2024 PMID: 39694200, DOI: 10.1016/j.clindermatol.2024.12.009.Peer-Reviewed Original ResearchLupus erythematosusSystemic diseaseTraining of dermatologistsManifestation of systemic diseaseSymptoms of systemic lupus erythematosusCutaneous manifestations of systemic diseaseAutoimmune connective tissue diseaseSystemic lupus erythematosusConnective tissue diseaseSigns of systemic diseasePatient carePhysical examination findingsInternal medicineCutaneous manifestationsYoung dermatologistsTissue diseaseClinicopathologic correlationPathological findingsExamination findingsSkin signsSystem pathologyField of dermatologyClinical signsObservation skills
2023
Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program
Chen G, Hong S, Ramachandran S, Gehlhausen J, Cohen J. Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program. Journal Of The American Academy Of Dermatology 2023, 90: 184-187. PMID: 37734665, DOI: 10.1016/j.jaad.2023.09.028.Peer-Reviewed Original ResearchVascular-Targeted Therapy for Systemic Lupus Erythematosus–Associated Vasculitis
Xu S, Patrignelli R, Ramachandran S, Koumpouras F, Desir D, Ko C, Gehlhausen J. Vascular-Targeted Therapy for Systemic Lupus Erythematosus–Associated Vasculitis. JAMA Dermatology 2023, 159: 460-462. PMID: 36884229, DOI: 10.1001/jamadermatol.2023.0077.Peer-Reviewed Original Research